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Introduction
Leishmaniasis is a group of tropical diseases caused by several species of protozoa parasites belonging to the genus Leishmania. Leishmaniasis affects more than 12 million people in 88 countries worldwide, constituting a growing public health problem in Africa, Asia and Latin America. 1 The existence of several different species of Leishmania makes it difficult to reduce the infection rate of the diseases caused by this parasite, in both tegumentary and visceral forms. The different epidemiological status of endemic regions and the trend toward urbanization require the adoption of different strategies for the control of leishmaniasis in Brazil. Cutaneous forms may heal spontaneously within a few months, or may develop into the other tegumentary leishmaniasis, which can cause serious facial disfiguration, morbidity, or mortality. 4 The current status of ATL, evaluated in Brazilian municipalities based on the records of the Health and Sanitation Department of the Ministry of Health, 3 revealed incidences ranging from 10.45 to 22.9 per 100,000 inhabitants, clearly indicating a geographical expansion of the disease. The Northern region has 34.9% of the total cases in the country and a global risk of acquiring the disease of 92.3 per 100,000 inhabitants, five times the national average. Nowadays, chemotherapy for leishmaniasis is still based mainly on daily intramuscular injections of pentavalent antimonials (Glucantime® and Pentostam®), diamines (Pentamidine®) and an antifungal polyene (Amfotericine® B), which are toxic, expensive, generate resistance, and require long-term treatment. There is an urgent need to develop new, more-effective and safer therapeutic agents in the fight against leishmaniasis. 4 Advances in combating leishmaniasis using natural products have been recently reviewed. 5, 6 Studies of plants producing alkaloids and acetogenins have yielded promising results against Leishmania spp., in particular extracts from species of the family Annonaceae.
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Annonaceae is a group of aromatic trees, shrubs, and lianas that occur mainly in tropical and subtropical regions. Previous chemical and pharmacological investigations on some species of this family have indicated the presence of important bioactive compounds with various pharmacological activities, including antiparasitic, in particular antileishmanial. [7] [8] [9] [10] [11] [12] [13] [14] Continuing our chemical and biological antileishmanial studies of members of the Annonaceae, we investigated the species Annona mucosa Jacq. [synonym Rollinia mucosa (Jacq.) Baill]. 15 This species provides the delicious fruit biribá, and popular reports reveal the use of its leaf extracts for the elimination of fleas and other insects infesting domestic animals. Chemical and pharmacological studies of species of Annonaceae have revealed the presence of alkaloids, acetogenins and lignoids, with proven antiprotozoal, antimicrobial and antifungal effects, [16] [17] [18] suggesting great chemical and pharmacological potential. In this study, extracts from A. mucosa (leaves and seeds), and the oxoaporphine alkaloid liriodenine, isolated from a dichloromethane extract of the leaves, were investigated in vitro against promastigote forms of L. amazonensis, L. braziliensis and L. guyanensis, and intracellular amastigote forms of L. amazonensis. The cytotoxicity to mice peritoneal macrophages was also evaluated. 
Animal experimentation guidelines
The experimental protocols conformed to the ethical principles in animal research adopted by the Comissão de Ética no 
Extraction and Isolation Procedures
Dried and powdered leaves (900 g) of A. mucosa were successively extracted with nhexane, dichloromethane and methanol, to yield hexane (18.4 g), dichloromethane (42.4 g), and methanol (19.6 g) extracts, after removal of each solvent. A similar procedure was followed with the seeds from fruits (300 g), using only hexane and methanol as solvents to obtain hexane (5.0 g), and methanol (15.0 g) extracts, respectively. TLC investigations indicated that the dichloromethane extract of the leaves contained the highest concentration of alkaloids. A part of this extract (11.2 g) was initially subjected to an acid-base extraction 12 to give dichloromethane alkaloid (0.25 g) and dichloromethane neutral (6.0 g) fractions.
The alkaloid fraction was subjected to silica gel column chromatography eluted with the gradient systems: hexane-dichloromethane from 100:0 to 10:90, followed by dichloromethane-methanol from 100:0 to 50:50, yielding 56 subfractions. The eluted subfractions were evaluated and pooled according to TLC analysis, to afford 6 groups of fractions (GF1-GF6). GF3 (20.0 mg) was purified by preparative TLC eluted with hexane-acetone (60:40, three times) affording 1 (2.0 mg) and 2 (10.0 mg) respectively. 
Antileishmanial activity against promastigote forms
A modification of the method described by Camacho et al. 20 was used to assess the in vitro antileishmanial activity. The screening was performed in eppendorfs maintained at 24 °C. Promastigote forms of Leishmania spp. ) were exposed to six concentrations (6, 12, 25, 50 and 100 µg.mL -1 ) of each extract and liriodenine. The samples were dissolved in DMSO. Up to 0.7% (v/v), DMSO had no effect on parasite growth. The activity of the samples was evaluated for six days by counting microscopically the number of live parasites that showed flagellar motility, using a Neubauer hemocytometer. The counts were compared with those of controls grown without a sample of extract, and with pentamidine isethionate (Sigma/P0547) used as the reference antileishmanial drug. Each concentration was assayed in duplicate. Results are expressed as concentrations inhibiting parasite growth by 50% (IC 50 ) after six days of incubation.
Antileishmanial activity against intracellular amastigote forms
The in vitro sensitivity of amastigote forms of Leishmania amazonensis (IFLA/BR/67/PH8) was determined in a mice peritoneal macrophage model. Peritoneal macrophages were collected from the peritoneal cavity of male BALB/c mice by washing with RPMI 160 medium four days after an intraperitoneal injection of 2.0 mL of sodium thioglycolate. The macrophages were dispensed into flatbottomed plastic 24-well tissue plates containing glass coverslips (13 mm), at a concentration of 5 x 10 5 /well ( 00 μL.well -1 ) in RPMI 1640 medium supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS) and 50 µg.mL -1 gentamycin, and incubated at 37 °C in a 5% CO 2 /air mixture. After 24 h, non-adherent cells were removed by washing with pre-warmed phosphatebuffered saline (PBS), and then the plated macrophages were infected with Leishmania amazonensis promastigotes, at a ratio of 10:1, and incubated at 34 °C in a 5% CO 2 /air mixture. The culture medium was renewed after 24 h, and a new culture medium containing 25 µg.mL -1 of each sample was added and the plates were incubated in the same conditions described above. Each extract and liriodenine were assayed in triplicate. The experiments were stopped at day 2, 3 or 5. The method described by Fumorola et al. 21 was used to make direct counts of the intracellular amastigotes. The infected macrophages from each sample were stained with May-Grunwald/Giemsa, and then evaluated microscopically to determine the percentage of infected macrophages and the number of amastigote forms per macrophage; 200 macrophages were inspected in each sample. 22 
Cytotoxicity in peritoneal macrophages
Cytotoxicity was studied after 96 h incubation of peritoneal macrophages with concentrations ranging from 6 to 100 µg.mL -1 of each extract and liriodenine. Peritoneal macrophages were collected from the peritoneal cavity of male BALB/c mice, as described in section 2.5.3. The macrophages were plated into 24-well tissue plates and incubated at 37 °C in a 5% CO 2 /air mixture. The viability of the macrophages was determined by direct counts, using a Neubauer hemocytometer. The counts were compared with those of controls incubated without a sample and with the antileishmanial reference drug pentamidine isethionate. Each concentration was assayed in triplicate. Results are expressed as 50% lethal concentrations (LC 50 ) after 96 h of incubation.
Statistical Analysis
All results were expressed as mean ±SEM for n experiments. Statistical evaluation was undertaken by analysis of variance (ANOVA) followed by the Student-Newman-Keuls test for multiple comparisons. A P value of less than 0.05 was considered statistically significant.
The IC 50 and LC 50 values at the 95% confidence interval were calculated using sigmoid dose-response curves in Graph Pad Prism 5.01 software.
Results and Discussion
Phytochemical investigation of the dichloromethane extract from the leaves of A. mucosa led to the isolation of the oxoaporphine alkaloids atherospermidine (1) and liriodenine (2) (Figure 2 ). The structures of these alkaloids were elucidated based on their spectroscopic data, mainly 1D and 2D NMR, and also comparison with literature data. 19 Atherospermidine (1) is reported for the first time in this species, and compound 2 has been previously described in the stem and fruits of this plant. 16 Atherospermidine (1) and liriodenine (2) are two oxoaporphine alkaloids that are widely found in almost all genera of Annonaceae, for which 2 is considered a chemotaxonomic marker. 23 The ), toxic (10 < LC 50 < 100 µg.mL -1 ), moderately toxic (100 < LC 50 < 1000 µg.mL ). 20 The results showed that four samples were toxic to mice peritoneal macrophages, and two extracts were moderately toxic. Cytotoxic activity (LC 50 ) was related to antileishmanial activity by determining their corresponding selectivity index (SI = LC 50 /IC 50 ) as shown in Table 2 . A value lower than 1 indicates that they are more toxic to peritoneal macrophages than to the parasites, and a value greater than 1 indicates higher selectivity against the parasites than against the peritoneal macrophages. The samples were also assayed on intracellular amastigote forms in three independent experiments. The percentage of infected macrophages ( Figure 3A ) and the parasite load ( Figure 3B ) decreased over time.
The percentage of infected macrophages at 24, 48 and 96 hours showed that the activity reduction was maintained for the hexane and dichloromethane extracts from the leaves of A. mucosa and liriodenine. The observed lower activity of the alkaloid liriodenine than of the plant extracts over this period can be explained only after complete investigation of the chemical constituents and biological evaluation of these extracts. The macrophages showed no apparent effect of toxicity such as rounding or detachment, even in the presence of the samples at 25 µg.mL . In our study, pentamidine was highly active, and after 48 h of incubation, eliminated 100% of infected macrophages. Nevertheless, the toxicity of pentamidine makes it a second choice, for use when treatment with antimony compounds is not effective. 5 In the same conditions, the extracts of A. mucosa and liriodenine showed more than 80% eliminated infected macrophages and 70% eliminated intracellular amastigotes. Because the extracts are a complex mixture of substances, purification of the active compounds might considerably increase their antileishmanial activity.
Additionally, in our assays, almost all the extracts showed antileishmanial activity, mainly the dichloromethane extract, which provided the cytotoxic and antileishmanial oxoaporphine alkaloids atherospermidine and liriodenine. 19 Therefore, these alkaloids may be responsible for the antileishmanial activity observed.
Conclusions
This study resulted in the isolation and identification of two oxoaporphine alkaloids, atherospermidine (1) and liriodenine (2), from the leaves of A. mucosa, 1 is reported for the first time in this species. These results contribute to the chemotaxonomic understanding of the family Annonaceae, especially the genus Annona. The results obtained in this study also confirm the importance of the selection of plant extracts used in folk medicine in screening programs in the search for new antileishmanial agents. Further investigation including the oxoaporphine alkaloid liriodenine and other constituents extracted from A. mucosa should focus on understanding their mechanisms of action, and encourage us to continue in vitro and in vivo investigations.
